Literature DB >> 15695278

Carbamazepine and false positive dexamethasone suppression tests for Cushing's syndrome.

Ronald C W Ma1, Wing Bun Chan, Wing Yee So, Peter C Y Tong, Juliana C N Chan, Chun Chung Chow.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15695278      PMCID： PMC548184          DOI： 10.1136/bmj.330.7486.299

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  15 in total

1.  Overnight dexamethasone suppression test: a reliable screen for Cushing's syndrome in the obese.

Authors:  Rosane Ness-Abramof; Dan Nabriski; Caroline M Apovian; Mark Niven; Eliahu Weiss; Menachem S Shapiro; Louis Shenkman
Journal:  Obes Res       Date:  2002-12

2.  The effect of anticonvulsants on the dexamethasone suppression test.

Authors:  G I Keitner; A E Fruzzetti; I W Miller; W H Norman; W A Brown
Journal:  Can J Psychiatry       Date:  1989-06       Impact factor: 4.356

3.  Hydrocortisone suppression test for Cushing syndrome. Therapy with anticonvulsants.

Authors:  A W Meikle; J B Stanchfield; C D West; F H Tyler
Journal:  Arch Intern Med       Date:  1974-12

4.  Reversal of dexamethasone suppression test nonsuppression in alcohol abusers.

Authors:  G Newsom; N Murray
Journal:  Am J Psychiatry       Date:  1983-03       Impact factor: 18.112

5.  Effects of weight loss on the dexamethasone suppression test.

Authors:  C K Edelstein; P Roy-Byrne; F I Fawzy; L Dornfeld
Journal:  Am J Psychiatry       Date:  1983-03       Impact factor: 18.112

6.  Interference by carbamazepine with the dexamethasone suppression test.

Authors:  M R Privitera; J F Greden; R W Gardner; J C Ritchie; B J Carroll
Journal:  Biol Psychiatry       Date:  1982-05       Impact factor: 13.382

Review 7.  Cytochrome P-450 3A4: regulation and role in drug metabolism.

Authors:  F P Guengerich
Journal:  Annu Rev Pharmacol Toxicol       Date:  1999       Impact factor: 13.820

8.  Nighttime salivary cortisol: a useful test for the diagnosis of Cushing's syndrome.

Authors:  Dimitris A Papanicolaou; Nancy Mullen; Ioannis Kyrou; Lynnette K Nieman
Journal:  J Clin Endocrinol Metab       Date:  2002-10       Impact factor: 5.958

Review 9.  The effects of anti-convulsant drugs on adrenal function.

Authors:  P Putignano; G A Kaltsas; M A Satta; A B Grossman
Journal:  Horm Metab Res       Date:  1998 Jun-Jul       Impact factor: 2.936

10.  Induction of CYP3A by ethanol in multiple in vitro and in vivo models.

Authors:  Dennis E Feierman; Zoya Melinkov; Amin A Nanji
Journal:  Alcohol Clin Exp Res       Date:  2003-06       Impact factor: 3.455
View more
  5 in total

1.  The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.

Authors:  Lynnette K Nieman; Beverly M K Biller; James W Findling; John Newell-Price; Martin O Savage; Paul M Stewart; Victor M Montori
Journal:  J Clin Endocrinol Metab       Date:  2008-03-11       Impact factor: 5.958

Review 2.  Drug-induced endocrine and metabolic disorders.

Authors:  Ronald C W Ma; Alice P S Kong; Norman Chan; Peter C Y Tong; Juliana C N Chan
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 3.  Drugs and HPA axis.

Authors:  Alberto Giacinto Ambrogio; Francesca Pecori Giraldi; Francesco Cavagnini
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

4.  A novel point mutation in the amino terminal domain of the human glucocorticoid receptor (hGR) gene enhancing hGR-mediated gene expression.

Authors:  Evangelia Charmandari; Takamasa Ichijo; William Jubiz; Smita Baid; Keith Zachman; George P Chrousos; Tomoshige Kino
Journal:  J Clin Endocrinol Metab       Date:  2008-09-30       Impact factor: 5.958

Review 5.  Antiepileptic Drugs in the Management of Cerebral Metastases.

Authors:  Meredith A Monsour; Patrick D Kelly; Lola B Chambless
Journal:  Neurosurg Clin N Am       Date:  2020-10       Impact factor: 2.509
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.